Quasar Medical unveils new global headquarters in Singapore

Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, announced today the opening of its Global Headquarters in Singapore. This milestone marks the company’s continued growth and reinforces its commitment to advancing medical innovation worldwide.

Quasar has operated out of Hong Kong since its founding in 1988 and will continue to maintain comprehensive business operations there as part of its global presence. Relocating the headquarters from Hong Kong to Singapore strategically positions the company at the heart of Asia’s MedTech ecosystem—a region at the forefront of medical technology and healthcare innovation. The expanded two-floor facility, acquired in 2021, adds 7,000 square feet to its existing 35,000 square feet and is designed to foster collaboration, accelerate innovation, and meet the needs of customers worldwide.

With enhanced extrusion, braiding, balloon manufacturing, advanced assembly automation, and cutting-edge inspection systems, the new headquarters strengthens Quasar’s ability to deliver high-volume production, customized catheter solutions, exceptional quality control, and greater supply chain flexibility.

Serving as the hub for global operations, the Singapore headquarters is supported by a local team of 180 employees across engineering, operations, program management, quality, and select corporate functions. The headcount is expected to exceed 300 within three years, based on Quasar’s ambitious growth strategy and supported by Singapore’s expanding talent pool. The Singapore facility demonstrates Quasar’s sustained commitment to the region and its strategic vision for the future of medical device manufacturing.

The new headquarters reflects the remarkable progress Quasar has achieved over its 38-year journey and serves as a foundation for the next chapter—connecting people, partners, and ideas to deliver medical device solutions that improve lives worldwide.